Abstract: The present disclosure relates to a cluster-based consensus approach for generating recombinant neuraminidase (NA) polypeptides. The disclosure further relates to influenza vaccine compositions comprising the recombinant NA polypeptides.
Type:
Grant
Filed:
March 27, 2019
Date of Patent:
January 13, 2026
Assignees:
Sanofi Pasteur Inc., VIR VZW, Universiteit Gent
Inventors:
Tod Strugnell, Eliud Oloo, Raymond Oomen, Thorsten Vogel, Xavier Saelens, Emma Job